Status:
UNKNOWN
Resynchronization in Paced Heart Failure Patients With Implantable Cardioverter Defibrillator (ICD) Indication
Lead Sponsor:
Schuechtermann-Klinik
Collaborating Sponsors:
Medtronic
Conditions:
Heart Failure
Left Bundle-Branch Block
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Today patients with a Cardiac Resynchronization Therapy (CRT) indication usually receive 2 ventricular leads, right ventricular (RV) apex and left ventricular (LV) (postero-) lateral, gaining a respon...
Eligibility Criteria
Inclusion
- EF less than 35 percent
- CAD or dilatative Cardiomyopathy
- Sinus rhythm
- NYHA III or IV, stable recompensated
- QRS more than 120ms
- LBBB
- Patient signed Consent Form
- Age more than 18 and less than 80 y
Exclusion
- permanent atrial Fibrillation
- permanent AV-Block II or III
- Tricuspidal- and or artificial aortic valve
- Indication for ACB or ACB less than 3 months ago
- myocardial infarction less than 3 months
- hypertrophic obstructive Cardiomyopathy; constrictive Pericarditis
- heartfailure with iv catecholamine therapy
- Manifested, uncontrolled, Hypo- oder Hyperthyreosis
- Severe renal insufficiency with Creatinine more than 2,5 mg per dL
- patients, who did not sign the consent form
- General medical conditions, which restrict the patient compliance
- Participation in another study
- life expectancy less than 1 y
- Age less than 18 y or more than 80y
- Pregnant women or Women of childbearing age
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01415024
Start Date
May 1 2011
Last Update
August 11 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schuechtermann-Klinik
Bad Rothenfelde, Lower Saxony, Germany, 49214